Atlas Trials

Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients

Clinical trial NCT05557240 · UNKNOWN

Trial details

NCT number
NCT05557240
Sponsor
Shanghai 10th People's Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioma, MalignantAntigen-specific VaccinesIndividualized Treatment
Start date
2022-09-13
Primary completion
2024-02-12
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.